Skip to main content
. Author manuscript; available in PMC: 2008 Apr 7.
Published in final edited form as: Behav Neurosci. 2004 Aug;118(4):715–729. doi: 10.1037/0735-7044.118.4.715

Figure 3.

Figure 3

Mean (± SEM) number of lever presses during Session 13 after 2-amino-5 phosphonopentanoic acid (AP-5) or vehicle infusions into the central nucleus of the amygdala. Previously AP-5-treated rats (n = 8) and previously vehicle-treated rats (n = 6) were divided into two groups (n = 7 per group). One group received an AP-5 infusion before Session 13; the remaining group received a vehicle infusion. AP-5 infusions decreased the number of lever presses regardless of previous drug history.